← Leaderboards
Howard J Worman
Columbia University Health Sciences
$18,931,900
Attributed
$27,995,548
Total exposure
18
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,995,548 · 18
By mechanism
R01$25,728,755 · 11
R21$1,154,751 · 3
R56$521,722 · 1
M01$385,820 · 1
R03$164,500 · 1
R13$40,000 · 1
Top collaborators
- Gregg G Gundersen21 shared
- Susan D. Michaelis7 shared
- Andrew R Marks5 shared
- William T Dauer4 shared
- Henry N Ginsberg4 shared
- John Pearce Morrow3 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Gregg G Gundersen$21,629,601
- John Pearce Morrow$3,392,672
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsCellsDefectNuclear EnvelopeMutationGenesAffectLeadLamin Type AMouse ModelLaminsNuclear Inner MembraneIntermediate Filament ProteinsCell NucleusPhysiologicalPathogenesisSyndromeMuscular DystrophiesNuclearSignal TransductionCardiomyopathiesPhenotypeComplexVariant
Grant awards (82)
Role for prelamin A in premature and physiological aging$579,727
R01 · FY2025 · AG
Using mouse models to dissect the roles of ZMPSTE24 and prelamin A in accelerated aging$82,250
R03 · FY2025 · AG · contact PI
Mechanistic Basis of Cardiac Laminopathy$722,502
R01 · FY2024 · HL · contact PI
Role for prelamin A in premature and physiological aging$591,558
R01 · FY2024 · AG
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$341,929
R01 · FY2024 · AR · contact PI
Using mouse models to dissect the roles of ZMPSTE24 and prelamin A in accelerated aging$82,250
R03 · FY2024 · AG · contact PI
2024 Intermediate Filaments Gordon Research Conference and Seminar$40,000
R13 · FY2024 · AR · contact PI
Mechanistic Basis of Cardiac Laminopathy$737,247
R01 · FY2023 · HL · contact PI
Role for prelamin A in premature and physiological aging$591,558
R01 · FY2023 · AG
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging$416,494
R01 · FY2023 · AG
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$352,505
R01 · FY2023 · AR · contact PI
Mechanistic Basis of Cardiac Laminopathy$737,247
R01 · FY2022 · HL · contact PI
Role for prelamin A in premature and physiological aging$623,433
R01 · FY2022 · AG
Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis$524,391
R01 · FY2022 · DK · contact PI
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations$452,970
R01 · FY2022 · HL
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging$416,494
R01 · FY2022 · AG
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$348,980
R01 · FY2022 · AR · contact PI
Mechanistic Basis of Cardiac Laminopathy$737,247
R01 · FY2021 · HL · contact PI
Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis$524,393
R01 · FY2021 · DK · contact PI
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations$452,970
R01 · FY2021 · HL
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging$416,494
R01 · FY2021 · AG
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging$405,000
R01 · FY2021 · AG
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$341,929
R01 · FY2021 · AR · contact PI
Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis$524,393
R01 · FY2020 · DK · contact PI
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations$452,970
R01 · FY2020 · HL
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging$420,591
R01 · FY2020 · AG
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$352,505
R01 · FY2020 · AR · contact PI
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations$22,156
R01 · FY2020 · HL
Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis$539,893
R01 · FY2019 · DK · contact PI
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations$452,970
R01 · FY2019 · HL
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging$451,364
R01 · FY2019 · AG
Nuclear Movement LINC Complex and Emery-Dreifuss Muscular Dystrophy$431,620
R01 · FY2019 · AR · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$352,000
R01 · FY2019 · AR · contact PI
Role of permanently farnesylated prelamin in the cardiovascular disease of aging$202,344
R21 · FY2019 · AG
Nuclear Movement LINC Complex and Emery-Dreifuss Muscular Dystrophy$431,620
R01 · FY2018 · AR · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$352,000
R01 · FY2018 · AR · contact PI
Role of permanently farnesylated prelamin in the cardiovascular disease of aging$258,709
R21 · FY2018 · AG
Role of permanently farnesylated prelamin in the cardiovascular disease of aging$38,711
R21 · FY2018 · AG
Nuclear Movement LINC Complex and Emery-Dreifuss Muscular Dystrophy$431,620
R01 · FY2017 · AR · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$352,000
R01 · FY2017 · AR · contact PI
Nuclear Movement LINC Complex and Emery-Dreifuss Muscular Dystrophy$431,620
R01 · FY2016 · AR · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$352,000
R01 · FY2016 · AR · contact PI
Nuclear Movement LINC Complex and Emery-Dreifuss Muscular Dystrophy$468,620
R01 · FY2015 · AR · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$352,000
R01 · FY2015 · AR · contact PI
The Nucleocytoskeleton in Progeria and Aging$333,571
R01 · FY2015 · HD
Nucleocytoplasmic Interactions and Dynamics in Emery-Dreifuss Muscular Dystrophy$521,722
R56 · FY2014 · NS · contact PI
The Nucleocytoskeleton in Progeria and Aging$332,546
R01 · FY2014 · HD
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$327,068
R01 · FY2013 · AR · contact PI
The Nucleocytoskeleton in Progeria and Aging$324,677
R01 · FY2013 · HD
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$344,282
R01 · FY2012 · AR · contact PI
The Nucleocytoskeleton in Progeria and Aging$342,125
R01 · FY2012 · HD
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$430,836
R01 · FY2011 · AR · contact PI
Nucleocytoplasmic Interactions and Dynamics in Emery-Dreifuss Muscular Dystrophy$345,144
R01 · FY2011 · NS · contact PI
The Nucleocytoskeleton in Progeria and Aging$342,125
R01 · FY2011 · HD
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$358,628
R01 · FY2010 · AR · contact PI
Nucleocytoplasmic Interactions and Dynamics in Emery-Dreifuss Muscular Dystrophy$348,666
R01 · FY2010 · NS · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$90,160
R01 · FY2010 · AR · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$9,949
R01 · FY2010 · AR · contact PI
Nucleocytoplasmic Interactions and Dynamics in Emery-Dreifuss Muscular Dystrophy$352,188
R01 · FY2009 · NS · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$347,922
R01 · FY2009 · AR · contact PI
Nucleocytoplasmic Interactions and Dynamics in Emery-Dreifuss Muscular Dystrophy$199,278
R01 · FY2009 · NS · contact PI
Nucleocytoplasmic Interactions and Dynamics in Emery-Dreifuss Muscular Dystrophy$352,188
R01 · FY2008 · NS · contact PI
Lamin A Mutation and Hutchinson-Gilford Progeria$251,255
R01 · FY2008 · AG · contact PI
Nucleocytoplasmic Interactions and Dynamics in Emery-Dreifuss Muscular Dystrophy$352,188
R01 · FY2007 · NS · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$301,723
R01 · FY2007 · AR · contact PI
Lamin A Mutation and Hutchinson-Gilford Progeria$256,383
R01 · FY2007 · AG · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$310,735
R01 · FY2006 · AR · contact PI
Lamin A Mutation and Hutchinson-Gilford Progeria$264,040
R01 · FY2006 · AG · contact PI
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$345,803
R01 · FY2005 · AR
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$345,803
R01 · FY2004 · AR
Lamin A in Adipocyte Differentation and Survival$163,500
R21 · FY2004 · DK
DUX4 and Facioscapulohumeral Muscular Dystrophy$156,453
R21 · FY2004 · NS
Pathogenesis of Emery-Dreifuss Muscular Dystrophy$345,803
R01 · FY2003 · AR
DUX4 and Facioscapulohumeral Muscular Dystrophy$171,534
R21 · FY2003 · NS
Lamin A in Adipocyte Differentation and Survival$163,500
R21 · FY2003 · DK
RIBAVIRIN PLUS INTERFERON ALPHA-2B IN TREATMENT OF CHRONIC HEPATITIS C$192,910
M01 · FY2002 · RR
RIBAVIRIN PLUS INTERFERON ALPHA-2B IN TREATMENT OF CHRONIC HEPATITIS C$192,910
M01 · FY2001 · RR
RIBAVIRIN PLUS INTERFERON ALPHA-2B IN TREATMENT OF CHRONIC HEPATITIS C$0
M01 · FY2001 · RR
PATHOBIOLOGY OF THE NUCLEAR ENVELOPE IN CANCER$239,710
R01 · FY2000 · CA
PATHOBIOLOGY OF THE NUCLEAR ENVELOPE IN CANCER$46,949
R01 · FY2000 · CA
RIBAVIRIN PLUS INTERFERON ALPHA-2B IN TREATMENT OF CHRONIC HEPATITIS C$0
M01 · FY2000 · RR
RIBAVIRIN PLUS INTERFERON ALPHA-2B IN TREATMENT OF CHRONIC HEPATITIS C$0
M01 · FY2000 · RR